Rationally Engineered

Not all Cyclodextrins are created equally

Captisol® is a patent protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to enable the creation of new products by significantly improving solubility, stability, bioavailability and dosing of active pharmaceutical ingredients (APIs).

Get Free SampleOrder Now

Upcoming Events

Visit us at Captisol booth # 1913 at AAPS 2017

Social

October 4, 2017 Melinta Therapeutics presents outcomes of Baxdela treatment of gram-positive and gram-negative pathogens at IDWeek https://t.co/lsH8Zb9n32

Your Partner in Solubility
The Clear Advantage

Partners

Merck
Baxter
Pfizer
Bristol-Myers Squibb
Amgen
Melinta
Lundbeck
Lilly
Celgene
Spectrum Pharmaceuticals